This study evaluated behavioral, biomarker, and imaging readouts in the mouse spared nerve injury (SNI) model of neuropathic ...

Charles River Laboratories is expanding its biotech incubation offering to even earlier in the developmental pipeline. The CRO’s new Charles River incubator program will provide regulatory and ...

Charles River Laboratories presents with optimistic growth expectations that seem a stretch given the business's current performance. Weak momentum in both stock price and business fundamentals ...

Charles River Laboratory's Gnotosafe Shipper (Fig ... National Research Council. Rodents: Laboratory Animal Management 86–87 (National Academy Press, Washington, DC, 1996).

At the close in NYSE,... Robert W. Baird analyst Eric Coldwell reiterated a Buy rating on Charles River Laboratories Intl on Friday, setting a price target of $453, which is approximately 17.38% ...

WILMINGTON, Mass., December 05, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of the Charles River Incubator Program (CIP), specializing in supporting ...

On Monday, Baird analyst Eric Coldwell revised the stock price target for Charles River Laboratories International, Inc. (NYSE:CRL) to $197.00, down from the previous target of $211.00. Despite this ...

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 7th Annual Evercore ISI HealthCONx Conference on Wednesday, December 4th, at 10:00 a.m. ET.